On September 3, 2024, the Federal Circuit issued a precedential decision affirming a district court decision where claims relating to “video-on-demand” systems did not constitute patentable subject matter because the claims...more
Summary - On June 10, 2024, the District Court for the District of New Jersey ordered Teva to delist five patents from the Orange Book for ProAir® HFA (albuterol sulfate) Inhalation Aerosol. The patents were directed to...more
On June 20, 2023, the Patent Trial and Appeal Board issued a decision in favor of Haug Partners client Sartorius BioAnalytical Instruments, Inc. (Gator Bio, Inc. v. Sartorius BioAnalytical Instruments, Inc., IPR2023-00215...more
On August 4, 2020, a bipartisan coalition of over 30 attorneys general led by California Attorney General Xavier Becerra and Louisiana Attorney General Jeff Landry sent a letter request to United States Health and Human...more
9/18/2020
/ Bayh-Dole Act ,
Biomedical Advanced Research and Development Authority (BARDA) ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Department of Defense (DOD) ,
Department of Health and Human Services (HHS) ,
Federal Acquisition Regulations (FAR) ,
Federal Funding ,
FOIA ,
Food and Drug Administration (FDA) ,
Freedom of Information ,
Intellectual Property Protection ,
Inventions ,
March-in-Rights ,
National Institute of Health (NIH) ,
Non-Exclusive License Agreements ,
Patented Medicines ,
Patents ,
Pharmaceutical Industry ,
Popular ,
Public Health ,
State Attorneys General ,
Vaccinations